Stock Analysis of Compass Therapeutics Inc. (CMPX) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code CMPX
Close 1.41
Change 0.0500 / 3.68 %
Volume 160171
Vol Change -49702.00 / 23.68 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bearish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index No Significant Stability


Fundamental View of Compass Therapeutics Inc.
PE (TTM)

-4.02

Very Poor
Price / Book

1.13

Very Good
Price / Sales

64.26

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

194000 K

Enterprise Value

170969 K

ROA (TTM)

-26.57

Very Poor
ROE (TTM)

-28.08

Very Poor
Net Margin (TTM)

-1597.89

Very Poor
Revenue

%

0
Net Profit

3.69 %

-40673.00 K
Debt to Equity

0.0081

Excellent
Altman Z Score

11.41

Excellent
Quick Ratio

0

Poor
Cash Ratio

19.54

Excellent


Highs/Lows of Compass Therapeutics Inc.
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week1.47 4.08 % 0.513 % 1.571.3528-May-2430-May-24
Two Week1.6 11.88 % 0.486 % 1.631.3520-May-2430-May-24
One Month1.44 2.08 % 4.80 % 1.791.3503-May-2430-May-24
Three Month1.78 20.79 % 3.56 % 2.341.3315-Mar-2425-Apr-24
Six Months1.65 14.55 % 15.54 % 2.341.1515-Mar-2405-Feb-24
One year2.9 51.38 % 26.26 % 3.451.1520-Jun-2305-Feb-24
Two year3.05 53.77 % 27.72 % 5.651.1523-Dec-2205-Feb-24


Technical View of Compass Therapeutics Inc.
RSI

38.36

Neutral
MACD

-0.052

Mild Bearish
ADX

16.15

Bearish
Super Trend

1.78

Mild Bearish
Williams %R

-83.33

Mild Bullish
CCI

-160.53

Mild Bullish


EMA 5

1.44

Mild Bearish
EMA 15

1.51

Strong Bearish
EMA 50

1.61

Strong Bearish
EMA 100

1.68

Strong Bearish
SMA 100

1.67

Bearish
SMA 200

1.78

Strong Bearish
SMA 5 / 20

1.45 / 1.56

Strong Bearish
SMA 15 / 50

1.53 / 1.64

Mild Bearish
SMA 50 / 200

1.64 / 1.78

Mild Bearish




Charts of Compass Therapeutics Inc.


Returns of Compass Therapeutics Inc. with Peers
Period / StockCMPXZVRACGENOM
1 Week-4.08%-0.215%-11.07%-3.62%
1 Mth-2.08%1.53%12.44%47.43%
3 Mth-20.79%-31.01%-15.89%18.41%
6mth-14.55%-2.31%227.45%-28.82%
1 Year-51.38%-7.74%112.75%-82.09%
2 Year-53.77%0.432%17.30%-82.89%
5 Years--98.86%-22.50%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Compass Therapeutics Inc. with Peers
Ratio / StockCMPXZVRACGENOM
PE-4.02-3.54-11.55-1.11
P/B1.132.303.111.22
ROA-26.57-36.03-17.98-50.69
ROE-28.08-64.85-26.93-109.94
Debt To Equity0.00810.6180.00961.07
Revenue0
% 		16563.00 K
58.38 % 		7500.00 K
0 % 		131876 K
14.30 %
Net Income-40673.00 K
3.69 % 		-39917.00 K
3.91 % 		-31559.00 K
6.34 % 		-175641.00 K
7.78 %


Technicals of Compass Therapeutics Inc. with Peers
Technical / StockCMPXZVRACGENOM-
ADX16.1523.7316.7944.35
CMF-0.229-0.1870.109-0.221
MFI27.3239.4867.8466.68
RSI38.3644.5349.7957.53
MACD Abv SignalFalseTrueTrueFalse
Price Above 50 MAFalseFalseFalseTrue-
Price Above 200 MAFalseFalseTrueFalse-


About : Compass Therapeutics Inc.

Address : 80 Guest Street, Boston, MA, United States, 02135
Tel : (617) 500-8099
URL : https://www.compasstherapeutics.com
Code : CMPX, ISIN : US20454B1044, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 05_Apr_2021
Employee Count : 32

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. The company's lead product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells. It also develops CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. The company was founded in 2014 and is headquartered in Boston, Massachusetts.


Note : All Data Generated at the End of Trading Hours (EOD Data)